| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.1% | 0.0% |
| Div Cover | 1.1 | 1.5 |
| Op Mrgn | 7.5% | 9.5% |
| ROCE | 14.6% |
| Latest | F'cast | |
|---|---|---|
| P/E | 43.6 | 34.6 |
| PEG | n/a | 1.8 |
| Pr/Revenue | 2.8 | 2.8 |
| Pr/Book | 4.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -11.8% | -100.0% |
| PBT | -15.8% | -100.0% |
| EPS | -10.1% | 20.0% |
| DPS | 2.0% | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 311.10 | 55.60 | 39.70p | 68.1 | 8.5 | +8% | 15.99p | 0.6% |
| 31-Dec-22 | 344.30 | 31.00 | 21.36p | 48.3 | n/a | -46% | 16.31p | 1.6% |
| 31-Dec-23 | 364.40 | 22.20 | 15.37p | 68.2 | n/a | -28% | 16.64p | 1.6% |
| 31-Dec-24 | 368.50 | 35.50 | 20.90p | 32.2 | 0.9 | +36% | 16.97p | 2.5% |
| 31-Dec-25 | 325.00 | 29.90 | 18.78p | 43.6 | n/a | -10% | 17.31p | 2.1% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Transaction in Own Shares | 28-Jul-2026 | 07:00 | RNS |
| Transaction in Own Shares | 21-Jul-2026 | 07:00 | RNS |
| Block Listing Return | 15-Jul-2026 | 07:00 | RNS |
| Fever-Tree toasts strong start to the year, shar... | 09-Jun-2026 | ShareCast |
| Transaction in Own Shares | 10-Mar-2026 | ShareCast |
| RBC Capital Markets raises target price on Fever... | 24-Feb-2026 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 862.00p |
| Change Today | 9.00p |
| % Change | 1.06 % |
| 52 Week High | 970.00 |
| 52 Week Low | 738.50 |
| Volume | 275,455 |
| Shares Issued | 112.60m |
| Market Cap | £970.58m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 21-May-26 | 25-Sep-25 |
| Paid | 26-Jun-26 | 17-Oct-25 |
| Amount | 11.34p | 5.97p |
| Time | Volume / Share Price |
| 16:35 | 90,951 @ 862.00p |
| 16:35 | 171 @ 862.00p |
| 16:35 | 27 @ 862.00p |
| 16:35 | 143 @ 862.00p |
| 16:35 | 57 @ 862.00p |
| CEO | Timothy (Tim) Daniel Warrillow |
| Finance Director | Andrew Branchflower |
You are here: research